Advertisement

Topics

USA Remains Top Priority for Launching New Drugs

20:00 EDT 26 Jul 2016 | Marketwired

RESEARCH TRIANGLE PARK, NC--(Marketwired - July 27, 2016) - Follow the money. That's the approach that drug companies take when they arrange their new product launch sequences. A recent study published by Cutting Edge Information found that 84% of surveyed pharmaceutical companies target the US in their major first market wave, meaning they launch their product first in America.

Among European companies, Germany and the United Kingdom are most commonly part of first wave launches, at 63% and 61%, respectively, among surveyed companies' launch sequences. In Canada, launches are evenly split among study participants between the first and second waves. Larger emerging market economies, such as India and Russia, see launches spread across multiple waves, with many drug manufacturers choosing third waves or later for those countries.

According to the study, Managing Market Access Launch Activities: Benchmarking Product Commercialization and Cross-Functional Coordination
, France, Italy, and Spain are predominantly part of second wave launches. Latin American markets are also primarily included in second- and third-wave launch targets, with the exception of larger markets, such as Brazil and Mexico, which are more product dependent.

"How pharmaceutical companies approach launch sequencing can have a major impact on launch sequences, especially in later waves," said Jacob Presson, data team leader at Cutting Edge Information. "Marginal gains can be extremely significant at this time during the launch sequencing process."

Managing Market Access Launch Activities: Benchmarking Product Commercialization and Cross-Functional Coordination, available at http://www.cuttingedgeinfo.com/research/market-access/reimbursement-launch-activities/, analyzes market access teams before and during the crucial launch window. The analysis includes spending, staffing, and internal coordination. Report highlights include:

For more information about market access and how drug companies position their products in new markets with sound data and a strong reimbursement profile, visit http://www.cuttingedgeinfo.com/library/market-access/.

Image Available: http://www.marketwire.com/library/MwGo/2016/7/25/11G107986/Images/July_27_2016_-_PH217_-_HH_-_84_percent_of_surveyed-219a42da69b5806c95210bd3879fbe52.jpg

Contact:Elio EvangelistaSenior Director of CommercializationCutting Edge Information919-403-6583 NEXT ARTICLE

More From BioPortfolio on "USA Remains Top Priority for Launching New Drugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...